Adam T Waickman
Affiliation: Johns Hopkins University
- Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptorAdam T Waickman
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Cancer Immunol Immunother 61:917-26. 2012..In light of these data, we believe that blockade of the A(2A) adenosine receptor is an attractive target for tumor immunotherapy that synergizes with other immunomodulatory approaches currently in clinical trials...